“…The infection rates in some parts of Africa and Europe are higher than the world average infection level, such as a 97.4% positive serological test for T. gondii in wild cats in Egypt (Dubey 2010), 62.3% in Albanian cats (Spada et al 2012), 70.9% in Algeria cats (Ouchetati et al 2021), 40.3%-76% in Turkish cats (Dubey 2010;Can et al 2014), 48.4% in Finnish cats (Jokelainen et al 2012), 42.4% in Switzerland (Schreiber et al 2021, 51.6% in Latvia (Deksne et al 2013), 58.95% in France (Afonso et al 2013), 60.8% in Estonia (Must et al 2015), 32.3% in Cyprus (Attipa et al 2021) and 24.2 to 60% in Spain (Montoya et al 2018;Candela et al 2022). The prevalence rates of T. gondii infection in cats in most of Asia are generally lower than the world average, such as 19.6% in Kuwait (Abdou et al 2013), 30.4% in Iraq (Switzer et al 2013), 24.5% in China (Ding et al 2017;Li et al 2022), 2.2 to 47.2% in Korea (Hong et al 2013;Jung et al 2017), 4.8 to 11% in Bangkok (Jittapalapong et al 2010Sukhumavasi et al 2012), 40% in Iran (Sharif et al 2009), 14.5% in Malaysia (Wana et al 2020), 9 to 26.7% in Japan (Matsuu et al 2017;Kyan et al 2021) and18.7% in Thailand (Huertas-López et al 2021). For countries in Americas, the prevalence rates were 8 to 84.4% in Brazil (Cavalcante et al 2006;Bastos et al 2014;Magalhães et al 2017;Lima et al 2018), and 6 to 66.7% in the United States (Lilly et al 2013;Ballash et al 2015;Scorza and Lappin 2017).…”